AGEN (agenusbio.com) Bozor qiymatining balans qiymatiga nisbati
Agenus (AGEN) rivojlanishi sezilarli miqdordagi tadqiqot va ishlanmalar (R&D) xarajatlari bilan cheklangan bo'lib, bu mustaqil biznes kengayishi uchun ma'lum bir chegara yaratadi. Biroq, antitanachalar ishlab chiqishda global korporatsiyalar bilan hamkorlik qilish strategiyasi alohida testlarning muvaffaqiyatsizligi bilan bog'liq moliyaviy xatarlarni minimallashtiradi va joriy ko'rsatkich -1.30 darajasida turibdi. Quyidagi narxlar tendentsiyasi grafigi sanoat gigantlariga qarshi bozor ulushi uchun ketayotgan shiddatli kurash sharoitida aktivning dinamikasini aks ettiradi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_AGEN_-_Agenus_-_Market-Capitalization-to-Net-Assets "AGEN Agenus, Inc Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
Agenus, Inc. (AGEN) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Agenus - AGEN
Ushbu ko'rsatkich aksiyalarining bozor qiymatini sof aktivlar miqdori bilan solishtirib, biznesning haqiqiy balans hisoboti nisbatida qanchalik hadda haddan tashqari baholanganligini aniqlash imkonini beradi. Bozor qiymatining buxgalteriya qiymatiga nisbati tendentsiyasini tahlil qilish orqali, investor Agenus (AGEN) immuno-onkologiya loyihalari portfelining kengayishi va B2B hamkorlik strategiyasi kompaniyaning moddiy aktivlar bazasiga nisbatan kotirovkalarda qanchalik darajada aks etganini baholashi mumkin.
Asosiy raqobatchilar
Bozor qiymatining balans qiymatiga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ATXS (Astria Therapeutics)|engene.com (ENGN) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RAPT (RAPT Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti JBIO|Bozor qiymatining balans qiymatiga nisbati Aclaris ACRS|Kapitallashuvning balans qiymatiga nisbati Kyverna Therapeutics, Inc KYTX|Kapitallashuvning sof aktivlarga nisbati TLSA (Tiziana Life Sciences)|cabalettabio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati VTYX (Ventyx Biosciences, Inc.)|THTX - Balans qiymatiga nisbatan bozor kapitallashuvi|AVTX: Bozor kapitallashuvining balans qiymatiga nisbati|Eledon Pharmaceuticals, Inc (ELDN) - Bozor kapitallashuvining balans qiymatiga nisbati|Climb Bio Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati zurabio.com|aTyr Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ADAG (adagene.com)|IMA - Bozor qiymatining balans qiymatiga nisbati|Shattuck Labs Inc - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Equillium Bio|CNTB - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati immunic-therapeutics.com IMUX|Atara Bio (ATRA) - Balans qiymatiga nisbatan bozor qiymati|IFRX (InflaRx NV) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati XFOR|Adicet Bio (ACET) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CELU (celularity.com)|INmune Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Akari Therapeutics AKTX|Enlivex Therapeutics Ltd. (ENLV) - Balans qiymatiga nisbatan bozor qiymati|QTTB: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GOVX|Bozor qiymatining balans qiymatiga nisbati EDSA (Edesa)|Kapitallashuvning sof aktivlarga nisbati IBIO (iBio Corporation)|Carisma Therapeutics Inc. - Bozor qiymatining balans qiymatiga nisbati|XTLB - Kapitallashuvning sof aktivlarga nisbati|Bolt Bio - Kapitallashuvning sof aktivlarga nisbati|HCWB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aptevotherapeutics.com|aimimmuno.com (AIM) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ADTX (Aditxt Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti gribio.com|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati Vyome Holdings Inc. (HIND)|REVB (Revelation Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati Indaptus Corp INDP|SCNI (Scinai Immunotherapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati affimed.com|Kapitallashuvning balans qiymatiga nisbati Allakos|HOOK (HOOKIPA Pharma, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGMS|ITOS (iTeos Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD